UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 164

Sortiert nach

A Systematic Review and Meta-analysis of Adjuvant and Neoadjuvant Chemotherapy for Upper Tract Urothelial Carcinoma

European urology, 2014-09, Vol.66 (3), p.529-541

2014

Link zum Volltext

Verfügbarkeit prüfen

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

Clinical cancer research, 2016-05, Vol.22 (10), p.2445-2452

2016

Link zum Volltext

Verfügbarkeit prüfen

Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial

Clinical cancer research, 2015-03, Vol.21 (5), p.1071-1077

2015

Link zum Volltext

Verfügbarkeit prüfen

Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma

Cancer immunology research, 2015-10, Vol.3 (10), p.1158-1164

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma

European journal of cancer (1990), 2015-11, Vol.51 (17), p.2580-2586

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model

The oncologist (Dayton, Ohio), 2017-03, Vol.22 (3), p.286-292

2017

Link zum Volltext

Verfügbarkeit prüfen

10% Tumor Diameter Shrinkage on the First Follow‐Up Computed Tomography Predicts Clinical Outcome in Patients With Advanced Renal Cell Carcinoma Treated With Angiogenesis Inhibitors: A Follow‐Up Validation Study

The oncologist (Dayton, Ohio), 2014-05, Vol.19 (5), p.507-514

2014

Link zum Volltext

Verfügbarkeit prüfen

Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation

Nature genetics, 2022-09, Vol.54 (9), p.1364-1375

2022

Link zum Volltext

Verfügbarkeit prüfen

BRAF Mutations in Metanephric Adenoma of the Kidney

European urology, 2012-11, Vol.62 (5), p.917-922

2012

Link zum Volltext

Verfügbarkeit prüfen

The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma

Clinical cancer research, 2013-09, Vol.19 (18), p.5218-5226

2013

Link zum Volltext

Verfügbarkeit prüfen

Germline EGFR mutations and familial lung cancer

Journal of clinical oncology, 2023-12, Vol.41 (34), p.101200JCO2301372-5284

2023

Link zum Volltext

Verfügbarkeit prüfen

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors

PloS one, 2015-06, Vol.10 (6), p.e0124711-e0124711

2015

Link zum Volltext

Verfügbarkeit prüfen

MET as a target in papillary renal cell carcinoma

Clinical cancer research, 2014-07, Vol.20 (13), p.3361-3363

2014

Link zum Volltext

Verfügbarkeit prüfen

First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis

Clinical genitourinary cancer, 2020-08, Vol.18 (4), p.244-251.e4

2020

Link zum Volltext

Verfügbarkeit prüfen

Is angiogenesis still an attractive target in metastatic castration‐resistant prostate cancer?

BJU international, 2015-10, Vol.116 (4), p.500-501

2015

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 and p16 Expression in Penile Squamous Cell Carcinoma From an Endemic Region

Clinical genitourinary cancer, 2020-06, Vol.18 (3), p.e254-e259

2020

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis

Pathology, research and practice, 2024-01, Vol.253, p.154918-154918, Article 154918

2024

Link zum Volltext

Verfügbarkeit prüfen

Adrenocortical carcinoma: The management of metastatic disease

Critical reviews in oncology/hematology, 2014-11, Vol.92 (2), p.123-132

2014

Link zum Volltext

Verfügbarkeit prüfen

Current role of cabozantinib in metastatic castration-resistant prostate cancer

Expert review of anticancer therapy, 2015-02, Vol.15 (2), p.151-156

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

BMC cancer, 2014-08, Vol.14 (1), p.592, Article 592

2014

Link zum Volltext

Verfügbarkeit prüfen

Identification of ALK gene alterations in urothelial carcinoma

PloS one, 2014-08, Vol.9 (8), p.e103325

2014

Link zum Volltext

Verfügbarkeit prüfen

IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer

JCO global oncology, 2022-11, Vol.8 (8), p.e2200154-e2200154

2022

Link zum Volltext

Verfügbarkeit prüfen

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study

Journal for immunotherapy of cancer, 2015-02, Vol.3 (1), p.3-3, Article 3

2015

Link zum Volltext

Verfügbarkeit prüfen

Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)

Journal of cancer research and clinical oncology, 2020-07, Vol.146 (7), p.1829-1845

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(152)

Publikationsform

Sprache

Englisch
(164)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Life Sciences & Biomedicine
(58)
Experiment
(54)
Particle Physics
(54)
Physics
(51)
Humans
(48)
Oncology
(43)
High Energy Physics - Experiment
(35)
Physical Sciences
(34)
Physics, Particles & Fields
(31)
Astronomy & Astrophysics
(30)
Physics, Nuclear
(30)
Male
(29)
Female
(20)
Middle Aged
(16)
Prognosis
(16)
Aged
(15)
Renal Cell Carcinoma
(15)
Kidney Neoplasms - Drug Therapy
(14)
Carcinoma, Renal Cell - Drug Therapy
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Systematic Review and Meta-analysis of Adjuvant and Neoadjuvant Chemotherapy for Upper Tract Urothelial Carcinoma

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial

Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma

Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma

Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model

10% Tumor Diameter Shrinkage on the First Follow‐Up Computed Tomography Predicts Clinical Outcome in Patients With Advanced Renal Cell Carcinoma Treated With Angiogenesis Inhibitors: A Follow‐Up Validation Study

Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation

BRAF Mutations in Metanephric Adenoma of the Kidney

The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma

Germline EGFR mutations and familial lung cancer

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors

MET as a target in papillary renal cell carcinoma

First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis

Is angiogenesis still an attractive target in metastatic castration‐resistant prostate cancer?

PD-L1 and p16 Expression in Penile Squamous Cell Carcinoma From an Endemic Region

Circulating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis

Risk factors and model for predicting toxicity‐related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Adrenocortical carcinoma: The management of metastatic disease

Current role of cabozantinib in metastatic castration-resistant prostate cancer

Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

Identification of ALK gene alterations in urothelial carcinoma

IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study

Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)

Suchergebnisse filtern